These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7803279)
21. Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia. Johnston DL; Meshinchi S; Opheim KE; Pallavicini MG; Feusner J; Woods WG; Lange BJ; Radich JP; Bernstein ID Br J Haematol; 2003 Nov; 123(3):431-5. PubMed ID: 14617001 [TBL] [Abstract][Full Text] [Related]
22. Trisomy 22: a subclone marker? Pinheiro RF; Lopes Ferrari Chauffaille Mde L; Vicari P; Rodrigues CA; Pelloso LA; Bordin JO; Yamamoto M Cancer Genet Cytogenet; 2003 May; 143(1):85-6. PubMed ID: 12742160 [No Abstract] [Full Text] [Related]
23. Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement. Schmidt CA; Przybylski G; Vogel D; Ludwig WD; Oettle H; Neubauer A; Siegert W Leukemia; 1994 Jan; 8(1):102-5. PubMed ID: 8289473 [TBL] [Abstract][Full Text] [Related]
24. N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6. Lübbert M; Oster W; Knopf HP; McCormick F; Mertelsmann R; Herrmann F Leukemia; 1993 Dec; 7(12):1948-54. PubMed ID: 8255093 [TBL] [Abstract][Full Text] [Related]
25. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061 [TBL] [Abstract][Full Text] [Related]
26. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes]. Xu KM Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073 [TBL] [Abstract][Full Text] [Related]
27. Use of fluorescence in situ hybridization to detect minimal residual disease in hematopoietic stem cell assays from peripheral blood stem cells of 2 patients with trisomy 8 acute myeloid leukemia. Dodge W; Cruz J; Zamkoff K; Hurd D; Pettenati MJ Stem Cells Dev; 2004 Feb; 13(1):23-6. PubMed ID: 15068690 [TBL] [Abstract][Full Text] [Related]
29. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071 [TBL] [Abstract][Full Text] [Related]
30. Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement. Beghini A; Ripamonti CB; Castorina P; Pezzetti L; Doneda L; Cairoli R; Morra E; Larizza L Cancer Genet Cytogenet; 2000 May; 119(1):26-31. PubMed ID: 10812167 [TBL] [Abstract][Full Text] [Related]
31. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9. Kumar R; Angelini S; Hemminki K Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681 [TBL] [Abstract][Full Text] [Related]
32. Identification of an inversion 16 coexisting with an isochromosome 22q by in situ hybridization in a case of childhood AML M4e. Gad SG; Callen DF; Kuss B; Downing JR; Behm F; Head D; Ribeiro RC; Raimondi SC Leukemia; 1993 Oct; 7(10):1658-62. PubMed ID: 8412329 [TBL] [Abstract][Full Text] [Related]
33. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study. Cuneo A; Bigoni R; Roberti MG; Bardi A; Rigolin GM; Piva N; Mancini M; Nanni M; Alimena G; Mecucci C; Matteucci C; La Starza R; Bernasconi P; Cavigliano P; Genini E; Zaccaria A; Testoni N; Carboni C; Castoldi G Haematologica; 1998 Jan; 83(1):21-6. PubMed ID: 9542319 [TBL] [Abstract][Full Text] [Related]
34. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents. Barletta E; Gorini G; Vineis P; Miligi L; Davico L; Mugnai G; Ciolli S; Leoni F; Bertini M; Matullo G; Costantini AS Carcinogenesis; 2004 May; 25(5):749-55. PubMed ID: 14688017 [TBL] [Abstract][Full Text] [Related]
35. Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient. Speletas M; Arvanitidi K; Tzoanopoulos D; Tsironidou V; Pardali E; Aggeli C; Tsapogas P; Kartalis G; Sideras P; Ritis K Haematologica; 2001 Sep; 86(9):918-27. PubMed ID: 11532619 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal change during 6-mercaptopurine (6-MP) therapy in juvenile myelomonocytic leukemia: the growth of a 6-MP-refractory clone that already exists at onset. Matsuda K; Matsuzaki S; Miki J; Hidaka E; Yanagisawa R; Nakazawa Y; Sakashita K; Kamijo T; Asami K; Sano K; Koike K Leukemia; 2006 Mar; 20(3):485-90. PubMed ID: 16424864 [TBL] [Abstract][Full Text] [Related]
37. [Low incidence of point mutation of N-ras oncogene in human gliomas]. Tsurushima H; Ohno T; Tsuboi K; Yoshii Y; Meguro K; Nose T No Shinkei Geka; 1995 Jul; 23(7):581-6. PubMed ID: 7637839 [TBL] [Abstract][Full Text] [Related]
38. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
39. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes. Liu TC; Lin SF; Chen TP; Liu HW; Chang JG J Formos Med Assoc; 1991 Sep; 90(9):825-30. PubMed ID: 1683380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]